INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,047,000 | -25.5% | 113,808 | -4.6% | 0.00% | -50.0% |
| Q3 2016 | $1,406,000 | -4.6% | 119,284 | +4.7% | 0.00% | 0.0% |
| Q2 2016 | $1,474,000 | -11.8% | 113,933 | +9.0% | 0.00% | 0.0% |
| Q1 2016 | $1,671,000 | -52.3% | 104,527 | -14.6% | 0.00% | -50.0% |
| Q4 2015 | $3,504,000 | +57.1% | 122,373 | +56.2% | 0.00% | +33.3% |
| Q3 2015 | $2,230,000 | -22.5% | 78,341 | -2.2% | 0.00% | -25.0% |
| Q2 2015 | $2,877,000 | +69.4% | 80,088 | +174.2% | 0.00% | +100.0% |
| Q1 2015 | $1,698,000 | +39.8% | 29,206 | +1.4% | 0.00% | 0.0% |
| Q4 2014 | $1,215,000 | +8.2% | 28,808 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $1,123,000 | -52.9% | 28,952 | -62.0% | 0.00% | -33.3% |
| Q2 2014 | $2,382,000 | +38.0% | 76,287 | +83.1% | 0.00% | 0.0% |
| Q1 2014 | $1,726,000 | -25.3% | 41,668 | -30.2% | 0.00% | 0.0% |
| Q4 2013 | $2,312,000 | +358.7% | 59,739 | +314.8% | 0.00% | +200.0% |
| Q3 2013 | $504,000 | +176.9% | 14,402 | +9.4% | 0.00% | – |
| Q2 2013 | $182,000 | – | 13,161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 105 | $0 | 0.00% |
| Sterling Investment Advisors, Ltd. | 250 | $0 | 0.00% |
| Front Row Advisors LLC | 60 | $0 | 0.00% |
| Executive Wealth Management, LLC | 20 | $0 | 0.00% |
| BARCLAYS PLC | 1,300 | $0 | 0.00% |
| BARCLAYS PLC | 33,172 | $10,000 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Financial Gravity Asset Management, Inc. | 50 | $0 | 0.00% |
| Vectors Research Management, LLC | 505 | $0 | 0.00% |